Brean Capital


Brean Capital Comments On Micron Technology, Inc. (MU) Following Lackluster Earnings Results

Micron Technology, Inc. (NASDAQ:MU) shares are falling 9.

Brean Capital Sets Expectations On Micron Technology, Inc. (MU) Ahead Of Earnings

Brean Capital analyst Mike Burton weighed in on Micron Technology, Inc. (NASDAQ:MU), as the the next key milestone for the company will be its fiscal …

Brean Capital Reiterated Buy on Neuralstem, Inc. (CUR) Following Preclinical Data for NSI-189

In a research report issued Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Neuralstem, Inc. (NASDAQ:CUR), with an $8.

Analysts Share Two Cents on FitBit Inc (FIT) and Qorvo Inc (QRVO) Following Meetings With Managements

Analysts from Oppenheimer and Brean Capital share their two cents on wearable fitness device maker Fitbit Inc (NYSE:FIT) and wireless chip maker Qorvo Inc (NASDAQ:QRVO), …

Brean Capital Weighs In on Himax Technologies, Inc. (ADR) (HIMX) and NVIDIA Corporation (NVDA) Following Earnings Results

With earnings season in full swing, Brean Capital analyst Mike Burton explains why he remains on the sidelines with semiconductor makers Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) and NVIDIA …

Analysts Change Price Targets on Alibaba Group Holding Ltd (BABA) and Yelp Inc (YELP)

Alibaba Group Holding Ltd Brean Capital analyst Fawne Jiang reiterated a Buy rating on shares of Alibaba Group Holding Ltd (NYSE:BABA), while raising the …

Analysts Have Mixed Outlooks on Earnings from Alibaba Group Holding Ltd (BABA) and GoPro Inc (GPRO)

Tech analysts provide earnings previews for e-commerce giant Alibaba Group Holding Ltd (NYSE:BABA) and action camera maker GoPro Inc (NASDAQ:GPRO). While one analyst is …

Biotech’s Week Ahead: Relypsa Inc (RLYP), GW Pharmaceuticals PLC-ADR (GWPH), Regeneron Pharmaceuticals Inc (REGN), and Exelixis, Inc. (EXEL)

It’s an exciting week ahead for pharmaceutical companies Relypsa Inc (NASDAQ:RLYP), GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Exelixis, Inc. (NASDAQ:EXEL), as …

Brean Capital Reiterates Buy on Heron Therapeutics Inc (HRTX) Following Positive FDA Update

In a research report issued Thuesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Heron Therapeutics Inc (NASDAQ:HRTX), with a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts